FIELD: medicine, oncology.
SUBSTANCE: group of inventions discloses an antitumor combination containing the acid salt of chidamide and the basic salt of celecoxib, in which the acid salt of chidamide is a hydrochloride or sulfate salt. Also the following is disclosed: a method of regulating the tumor microenvironment during cancer immunotherapy, a method of treating cancer, and a method of treating cancer by regulating the tumor microenvironment and increasing the rate of formation of the immune response.
EFFECT: increase in the rate of formation of the immune response and antitumor activity.
31 cl, 5 tbl, 14 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE | 2018 |
|
RU2778887C2 |
| ADMINISTRATION OF SUMO-ACTIVATING ENZYME INHIBITOR AND CHECKPOINT INHIBITORS | 2020 |
|
RU2830077C2 |
| COMBINATION INCLUDING IMMUNE-STIMULATING OLIGONUCLEOTIDES | 2016 |
|
RU2766693C2 |
| THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS THEREOF WITH ANTICANCER AGENTS | 2019 |
|
RU2824502C2 |
| FLUOROVINYLBENZAMIDE COMPOUND AS A PD-L1 IMMUNOMODULATOR | 2020 |
|
RU2789450C1 |
| IMMUNE SYSTEM STIMULATING MICELLAR COMPOSITION | 2020 |
|
RU2832220C1 |
| IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS | 2017 |
|
RU2753523C2 |
| NOVEL ANTI-PD-L1 ANTIBODIES | 2016 |
|
RU2736151C2 |
| COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR | 2014 |
|
RU2714142C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION | 2016 |
|
RU2711380C2 |
